Literature DB >> 27026202

"Targeting astrocytes in CNS injury and disease: A translational research approach".

Angela R Filous1, Jerry Silver2.   

Abstract

Astrocytes are a major constituent of the central nervous system. These glia play a major role in regulating blood-brain barrier function, the formation and maintenance of synapses, glutamate uptake, and trophic support for surrounding neurons and glia. Therefore, maintaining the proper functioning of these cells is crucial to survival. Astrocyte defects are associated with a wide variety of neuropathological insults, ranging from neurodegenerative diseases to gliomas. Additionally, injury to the CNS causes drastic changes to astrocytes, often leading to a phenomenon known as reactive astrogliosis. This process is important for protecting the surrounding healthy tissue from the spread of injury, while it also inhibits axonal regeneration and plasticity. Here, we discuss the important roles of astrocytes after injury and in disease, as well as potential therapeutic approaches to restore proper astrocyte functioning.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocytes; Astrogliosis; BBB; Disease; GFAP; Glial scar; Heterogeneity; Proteoglycan; SCI; Therapeutics; Transplantation

Mesh:

Year:  2016        PMID: 27026202      PMCID: PMC5035184          DOI: 10.1016/j.pneurobio.2016.03.009

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  250 in total

1.  Origin of new glial cells in intact and injured adult spinal cord.

Authors:  Fanie Barnabé-Heider; Christian Göritz; Hanna Sabelström; Hirohide Takebayashi; Frank W Pfrieger; Konstantinos Meletis; Jonas Frisén
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

2.  Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy.

Authors:  Amanda Emirandetti; Renata Graciele Zanon; Mario Sabha; Alexandre Leite Rodrigues de Oliveira
Journal:  Brain Res       Date:  2006-05-22       Impact factor: 3.252

3.  Blood monocytes and spleen macrophages differentiate into microglia-like cells when cultured on astrocytes.

Authors:  J Sievers; J Schmidtmayer; R Parwaresch
Journal:  Ann Anat       Date:  1994-01       Impact factor: 2.698

4.  Essential protective roles of reactive astrocytes in traumatic brain injury.

Authors:  D J Myer; G G Gurkoff; S M Lee; D A Hovda; M V Sofroniew
Journal:  Brain       Date:  2006-07-05       Impact factor: 13.501

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Astrocyte uncoupling as a cause of human temporal lobe epilepsy.

Authors:  Peter Bedner; Alexander Dupper; Kerstin Hüttmann; Julia Müller; Michel K Herde; Pavel Dublin; Tushar Deshpande; Johannes Schramm; Ute Häussler; Carola A Haas; Christian Henneberger; Martin Theis; Christian Steinhäuser
Journal:  Brain       Date:  2015-03-12       Impact factor: 13.501

7.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

8.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

9.  Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter.

Authors:  Y Yatomi; R Tanaka; H Shimura; N Miyamoto; K Yamashiro; M Takanashi; T Urabe; N Hattori
Journal:  Neuroscience       Date:  2013-04-18       Impact factor: 3.590

10.  Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.

Authors:  Amélie O Dumont; Stéphanie Goursaud; Nathalie Desmet; Emmanuel Hermans
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more
  53 in total

Review 1.  Glia-immune interactions post-ischemic stroke and potential therapies.

Authors:  Jessica Hersh; Shao-Hua Yang
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-11

2.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

Review 3.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

Review 4.  Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.

Authors:  Michael A Lane; Angelo C Lepore; Itzhak Fischer
Journal:  Expert Rev Neurother       Date:  2016-12-21       Impact factor: 4.618

5.  Biomaterial strategies for creating in vitro astrocyte cultures resembling in vivo astrocyte morphologies and phenotypes.

Authors:  Manoj K Gottipati; Jonathan M Zuidema; Ryan J Gilbert
Journal:  Curr Opin Biomed Eng       Date:  2020-07-04

Review 6.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

7.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

8.  Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.

Authors:  Xiang Fan; Yinghua Jiang; Zhanyang Yu; Qi Liu; Shuzhen Guo; Xiaochuan Sun; Klaus van Leyen; MingMing Ning; Xiumei Gao; Eng H Lo; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2017-06-04       Impact factor: 6.829

9.  Ornithine decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.

Authors:  David Kapfhamer; James McKenna; Caroline J Yoon; Tracy Murray-Stewart; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 10.  Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect.

Authors:  Wei Cai; Kai Zhang; Peiying Li; Ling Zhu; Jing Xu; Boyu Yang; Xiaoming Hu; Zhengqi Lu; Jun Chen
Journal:  Ageing Res Rev       Date:  2016-09-30       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.